Volume 64, Issue 4, Pages 1480-1486 (October 2003) Glycemic control in diabetic CAPD patients assessed by continuous glucose monitoring system (CGMS) Jennifer Marshall, Peter Jennings, Adrian Scott, Richard J. Fluck, Christopher W. Mcintyre Kidney International Volume 64, Issue 4, Pages 1480-1486 (October 2003) DOI: 10.1046/j.1523-1755.2003.00209.x Copyright © 2003 International Society of Nephrology Terms and Conditions
Figure 1 Correlation of interstitial fluid (ISF) glucose as measured by continuous glucose monitoring system (CGMS) compared with venous blood glucose levels, r2 = 0.82, P < 0.0001. Kidney International 2003 64, 1480-1486DOI: (10.1046/j.1523-1755.2003.00209.x) Copyright © 2003 International Society of Nephrology Terms and Conditions
Figure 2 Bland-Altman plot comparing interstitial fluid (ISF) glucose as measured by continuous glucose monitoring system (CGMS) compared with venous blood glucose levels. Kidney International 2003 64, 1480-1486DOI: (10.1046/j.1523-1755.2003.00209.x) Copyright © 2003 International Society of Nephrology Terms and Conditions
Figure 3 Mean 24-hour continuous glucose monitoring system (CGMS) glucose level for each of the phases of study. Kidney International 2003 64, 1480-1486DOI: (10.1046/j.1523-1755.2003.00209.x) Copyright © 2003 International Society of Nephrology Terms and Conditions
Figure 4 Coefficient of variability for 24-hour glucose level for each of the phases of study. Kidney International 2003 64, 1480-1486DOI: (10.1046/j.1523-1755.2003.00209.x) Copyright © 2003 International Society of Nephrology Terms and Conditions
Figure 5 The 24-hour completed continuous glucose monitoring system (CGMS) glucose profiles for all patients in each phase of study, phase 1 (A), phase 2 (B), and phase 3 (C). Kidney International 2003 64, 1480-1486DOI: (10.1046/j.1523-1755.2003.00209.x) Copyright © 2003 International Society of Nephrology Terms and Conditions
Figure 6 The 24-hour completed continuous glucose monitoring system (CGMS) glucose profiles for a single representative patient in each phase of study, phase 1 (A), phase 2 (B), and phase 3 (C). Kidney International 2003 64, 1480-1486DOI: (10.1046/j.1523-1755.2003.00209.x) Copyright © 2003 International Society of Nephrology Terms and Conditions